CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$1.95
-0.06 (-2.75%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,890.7% upside
Low Target
$25.17
Average Target
$38.72
High Target
$55.57
Current Price
$1.95
Current
$1.95
$1.95
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Scenario Analysis
Bear Case
$25.17
1,194.1%
Low target
Base Case
$38.72
+1,890.7%
Avg target
Bull Case
$55.57
+2,757.1%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.19
-53.6% from high
52-Week Low
$0.49
+295.9% from low
Target vs 52W High
$38.72
+824.1% vs high
Next Earnings Report
Nov 16, 2026 · Before Market Open
1d
tomorrow
EPS Est: $0.04
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |